Aspiriant LLC’s iShares MSCI EAFE ETF EFA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.32M Buy
85,649
+1,978
+2% +$198K 0.24% 49
2025
Q4
$8.03M Buy
83,671
+34,474
+70% +$3.27M 0.23% 51
2025
Q3
$4.59M Sell
49,197
-50,611
-51% -$4.6M 0.14% 66
2025
Q2
$8.92M Buy
99,808
+44,038
+79% +$3.76M 0.28% 42
2025
Q1
$4.56M Buy
55,770
+927
+2% +$74.7K 0.16% 58
2024
Q4
$4.15M Buy
54,843
+7,313
+15% +$579K 0.15% 61
2024
Q3
$3.97M Sell
47,530
-272
-0.6% -$21.9K 0.15% 61
2024
Q2
$3.74M Buy
47,802
+2,295
+5% +$182K 0.15% 63
2024
Q1
$3.63M Buy
45,507
+9,516
+26% +$728K 0.15% 65
2023
Q4
$2.71M Buy
35,991
+4
+0% +$283 0.12% 78
2023
Q3
$2.48M Sell
35,987
-99
-0.3% -$7.09K 0.13% 78
2023
Q2
$2.62M Sell
36,086
-205
-0.6% -$14.9K 0.13% 78
2023
Q1
$2.6M Buy
36,291
+2,348
+7% +$164K 0.14% 76
2022
Q4
$2.23M Sell
33,943
-8,419
-20% -$527K 0.11% 82
2022
Q3
$2.37M Sell
42,362
-13,571
-24% -$846K 0.12% 75
2022
Q2
$3.49M Buy
55,933
+4,936
+10% +$336K 0.17% 60
2022
Q1
$3.75M Sell
50,997
-922
-2% -$69K 0.21% 57
2021
Q4
$4.09M Buy
51,919
+698
+1% +$55.3K 0.22% 55
2021
Q3
$4M Buy
51,221
+198
+0.4% +$15.8K 0.23% 49
2021
Q2
$4.03M Buy
51,023
+1,822
+4% +$145K 0.23% 46
2021
Q1
$3.73M Buy
49,201
+5,604
+13% +$422K 0.24% 42
2020
Q4
$3.18M Buy
43,597
+2,029
+5% +$139K 0.22% 46
2020
Q3
$2.65M Buy
41,568
+683
+2% +$43.7K 0.21% 57
2020
Q2
$2.49M Buy
40,885
+2,019
+5% +$117K 0.23% 48
2020
Q1
$2.08M Sell
38,866
-38,940
-50% -$2.47M 0.2% 48
2019
Q4
$5.4M Sell
77,806
-22,288
-22% -$1.51M 0.5% 33
2019
Q3
$6.53M Sell
100,094
-6,756
-6% -$435K 0.58% 33
2019
Q2
$7.02M Sell
106,850
-5,357
-5% -$351K 0.59% 34
2019
Q1
$7.28M Sell
112,207
-107,241
-49% -$6.76M 0.59% 35
2018
Q4
$12.9M Buy
219,448
+1,250
+0.6% +$78.1K 0.98% 25
2018
Q3
$14.8M Sell
218,198
-47,228
-18% -$3.19M 1.27% 19
2018
Q2
$17.8M Sell
265,426
-67,819
-20% -$4.75M 1.52% 18
2018
Q1
$23.2M Buy
333,245
+292,978
+728% +$20.9M 2.03% 13
2017
Q4
$2.83M Sell
40,267
-317,693
-89% -$22.1M 0.83% 25
2017
Q3
$24.5M Buy
357,960
+232,452
+185% +$15.5M 2.05% 15
2017
Q2
$8.18M Sell
125,508
-342,659
-73% -$22.2M 0.71% 33
2017
Q1
$11M Sell
468,167
-46,499
-9% -$2.81M 0.94% 26
2016
Q4
$7.83M Buy
514,666
+408,362
+384% +$23.5M 0.71% 25
2016
Q3
$6.29M Sell
106,304
-4,583
-4% -$266K 0.63% 25
2016
Q2
$6.19M Sell
110,887
-6,631
-6% -$382K 0.58% 25
2016
Q1
$6.72M Buy
117,518
+74,808
+175% +$4.12M 0.64% 25
2015
Q4
$2.51M Buy
42,710
+2,425
+6% +$146K 0.28% 30
2015
Q3
$2.31M Buy
40,285
+25,105
+165% +$1.55M 0.19% 32
2015
Q2
$964K Buy
15,180
+23
+0.2% +$1.53K 0.09% 51
2015
Q1
$973K Sell
15,157
-70
-0.5% -$4.41K 0.13% 42
2014
Q4
$926K Buy
15,227
+1,238
+9% +$77.3K 0.12% 41
2014
Q3
$897K Buy
13,989
+2,307
+20% +$154K 0.13% 37
2014
Q2
$799K Sell
11,682
-4,464
-28% -$306K 0.11% 51
2014
Q1
$1.08M Sell
16,146
-418
-3% -$27.6K 0.16% 46
2013
Q4
$1.11M Buy
16,564
+11,289
+214% +$738K 0.17% 38
2013
Q3
$337K Sell
5,275
-9,855
-65% -$604K 0.06% 44
2013
Q2
$867K Buy
+15,130
New +$915K 0.14% 36

Other funds holding EFA

Aspiriant LLC's EFA Position: Q1 2026 in Review

Aspiriant LLC increased its iShares MSCI EAFE ETF (EFA) stake by 2.4% in Q1 2026, buying an estimated $198K and bringing the position to 85,649 shares worth $8.32M. The position accounts for 0.24% of the portfolio, ranked #49.

Aspiriant LLC first reported a position in EFA in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.5M in Q3 2017. 2,199 funds tracked by Wall St. Rank hold EFA as of Q1 2026.

  • Aspiriant LLC held 85,649 shares of iShares MSCI EAFE ETF worth $8.32M as of Q1 2026.
  • Aspiriant LLC bought 1,978 iShares MSCI EAFE ETF shares in Q1 2026, an estimated $198K.
  • iShares MSCI EAFE ETF made up 0.24% of Aspiriant LLC's portfolio in Q1 2026, its #49 holding.
  • Aspiriant LLC first reported a position in iShares MSCI EAFE ETF in Q2 2013 and has held it in 52 quarters since.
  • Aspiriant LLC's iShares MSCI EAFE ETF position peaked at $24.5M in Q3 2017.
  • 2,199 funds tracked by Wall St. Rank held iShares MSCI EAFE ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.